Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Medizinische Klinik - Intensivmedizin und Notfallmedizin

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 22810435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?

  2011cited by this paper
• Olmesartan, an AT1 Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis

  2011cited by this paper
• Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.

  2011cited by this paper
• Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.

  2011cited by this paper
• Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention

  2011cited by this paper
• Inflammation and cardiac outcome

  2011cited by this paper
• Granulocyte colony‐stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single‐blind, randomized, placebo‐controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM‐AMI) Trial

  2010cited by this paper
• Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*

  2010cited by this paper
• MCP-1: chemoattractant with a role beyond immunity: a review.

  2010cited by this paper
• Cardiogenic shock: The role of inflammation

  2010cited by this paper
• Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures

  2010cited by this paper
• Impaired regulation of cardiac function in sepsis, SIRS, and MODS.

  2009cited by this paper
• sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.

  2009cited by this paper
• Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective

  2009cited by this paper
• Cardiogenic shock in acute coronary syndrome.

  2009cited by this paper
• Effect of intra-aortic balloon pump support on microcirculation during high-risk percutaneous intervention

  2009cited by this paper
• Septischer Kreislaufschock und septische Kardiomyopathie

  2009cited by this paper
• Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction

  2009cited by this paper
• Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock

  2008cited by this paper
• Beta-blockade does not alter plasma cytokine concentrations and ventricular function in young adults with right ventricular dysfunction secondary to operated congenital heart disease.

  2008cited by this paper
• Interleukin-6 as diagnostic marker for neonatal sepsis: determination of Access IL-6 cutoff for newborns.

  2008cited by this paper
• Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.

  2008cited by this paper
• A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

  2008cited by this paper
• Association of interleukin-10 level with increased 30-day mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.

  2007cited by this paper
• The prognostic value of monocyte chemoattractant protein-1/CCL2 in acute coronary syndromes.

  2007cited by this paper
• The Interferons: 50 Years after Their Discovery, There Is Much More to Learn*

  2007cited by this paper
• Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.

  2007cited by this paper
• Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.

  2007cited by this paper
• A DNA vaccine encoding CCL4/MIP-1beta enhances myocarditis in experimental Trypanosoma cruzi infection in rats.

  2006cited by this paper
• A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.

  2006cited by this paper
• Identification and Characterization of Two Genes (MIP-1β, VE-CADHERIN) Implicated in Acute Rejection in Human Heart Transplantation: Use of Murine Models in Tandem With cDNA Arrays

  2005cited by this paper
• Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.

  2005cited by this paper
• Reversible cardiomyopathy caused by administration of interferon alpha.

  2005cited by this paper
• Association between the TNF-2 allele and a better survival in cardiogenic shock.

  2004cited by this paper
• Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.

  2003cited by this paper
• Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a “Sepsis-Like” Syndrome

  2002cited by this paper
• CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.

  2001cited by this paper
• The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene.

  2000cited by this paper
• Cardiodepression by tumor necrosis factor-alpha.

  1999cited by this paper
• Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

  1999cited by this paper
• Systemic inflammation in patients with heart failure.

  1998cited by this paper
• Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles.

  1998cited by this paper
• Tumor necrosis factor α decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes

  1994cited by this paper
• Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.

  1993cited by this paper
• Biological and structural properties of MIP-1 alpha expressed in yeast.

  1992cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• The cardiovascular response of normal humans to the administration of endotoxin.

  1989cited by this paper
• Detection of circulating tumor necrosis factor after endotoxin administration.

  1988cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• The effects of extracorporeal blood purification (oXiris®) in patients with cardiogenic shock who require VA-ECMO (CLEAN ECMO): a prospective, open-label, randomized controlled pilot study

  2025cites this paper
• Impact of mild therapeutic hypothermia on plasma markers of inflammation and apoptosis in non-resuscitated patients with acute myocardial infarction and cardiogenic shock

  2025cites this paper
• The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review

  2024cites this paper
• Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence

  2024cites this paper
• Cardiogenic Shock: Focus on Non-Cardiac Biomarkers

  2024cites this paper
• Extending the ‘host response’ paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities

  2023cites this paper
• RETRACTED ARTICLE: Enhancement of cardiac angiogenesis in a myocardial infarction rat model using selenium alone and in combination with PTXF: the role of Akt/HIF-1α signaling pathway

  2023cites this paper
• Circulating Monocyte Chemoattractant Protein-1 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Substudy of SHOCK-COOL Trial

  2022cites this paper
• Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction

  2022cites this paper
• Multitarget Approach to Cardiogenic Shock after Acute Myocardial Infarction: Extracorporeal Life Support (ECLS) and Beyond

  2021cites this paper
• Evaluation of the Oxiris Membrane in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support: Study Protocol for a Single Center, Single-Blind, Randomized Controlled Trial

  2021cites this paper
• Thymoquinone protects against cardiac mitochondrial DNA loss, oxidative stress, inflammation and apoptosis in isoproterenol-induced myocardial infarction in rats

  2021cites this paper
• Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study

  2021cites this paper
• Prognostic role of procalcitonin in ST-elevation myocardial infarction complicated by cardiogenic shock

  2021cites this paper
• Association between neutrophil-to-albumin ratio and mortality in patients with cardiogenic shock: a retrospective cohort study

  2020cites this paper
• An IL-6-IL-8 score derived from principal component analysis is predictive of adverse outcome in acute myocardial infarction

  2020cites this paper
• Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases

  2020cites this paper
• Platelet-leukocyte aggregate is associated with adverse events after surgical intervention for rheumatic heart disease

  2019cites this paper
• Lactate and other biomarkers as treatment target in cardiogenic shock.

  2019cites this paper
• Revascularisation and mechanical circulatory support in patients with ischaemic cardiogenic shock

  2019cites this paper
• Predicting outcomes in cardiogenic shock: are we at risk of having too many scores but too little information?

  2019cites this paper
• Molecular signature of cardiogenic shock.

  2019cites this paper
• Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy is associated with improved survival

  2018cites this paper
• Optimal course of treatment in acute cardiogenic shock complicating myocardial infarction

  2018cites this paper
• Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway.

  2018cites this paper
• Alcohol attenuates myocardial ischemic injury

  2017cites this paper
• Preventive effect of hesperidin modulates inflammatory responses and antioxidant status following acute myocardial infarction through the expression of PPAR‑γ and Bcl‑2 in model mice.

  2017cites this paper
• Investigating Prevalence and Pattern of Long‐term Cardiovascular Disorders in Sulphur Mustard‐exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients’ Feedback on Therapy

  2017cites this paper
• Effect of inflammatory mediators on cardiovascular function

  2016cites this paper
• Effects of myocardial mir-124 on the expression of insulin-like growth factor-1 (IGF-1) in hypothyroid rats

  2016cites this paper
• Interferon-γ in foam cell formation and progression of atherosclerosis.

  2015cites this paper
• „Bridge to recovery“ – Implantation einer Impella® CP bei infarktbedingtem kardiogenem Schock

  2015cites this paper
• SH2B3 Is a Genetic Determinant of Cardiac Inflammation and Fibrosis

  2015cites this paper
• [Intra-aortic balloon pump (IABP) counterpulsation. Do we still need it and if so when?].

  2015cites this paper
• The Role and Predictive Value of Cytokines in Atherosclerosis and Coronary Artery Disease.

  2015cites this paper
• Mechanical circulatory support in cardiogenic shock.

  2014cites this paper
• The Th17/Treg imbalance in patients with cardiogenic shock

  2014cites this paper
• Cardiogenic shock - diagnostic and therapeutic options in the light of new scientific data.

  2014cites this paper
• Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI

  2013cites this paper
• Stress-induced hyperglycemia and activation of systemic inflammation as components of acute cardiac insufficiency development in acute myocardial infarction patients with ST segment elevation and preserved left ventricular ejection fraction

  2013cites this paper
• Inflammatory biomarkers for predicting cardiovascular disease.

  2013cites this paper
• Evidence-based Management of Cardiogenic Shock After Acute Myocardial Infarction.

  2013cites this paper